Trinity Biotech Files Routine 6-K Report
Ticker: TRIB · Form: 6-K · Filed: Jan 28, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Jan 28, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Trinity Biotech filed a standard 6-K, no major news.
AI Summary
Trinity Biotech plc filed a Form 6-K on January 28, 2025, reporting its status as a foreign private issuer. The company, incorporated in Ireland with its principal executive office in Bray, Co. Wicklow, is required to file annual reports under Form 20-F. This filing does not appear to contain specific financial or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Trinity Biotech is fulfilling its regular reporting obligations as a foreign private issuer, which is standard for companies listed on US exchanges but based internationally.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- IDA Business Park, Bray, Co. Wicklow, Ireland (location) — Principal Executive Office
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to report material information that the issuer makes public in its home country.
What does it mean that Trinity Biotech is a 'foreign private issuer'?
A foreign private issuer is a foreign entity that is not a foreign government and meets certain other criteria, allowing it to file reports under different rules than domestic US companies, such as using Form 20-F for annual reports.
When was this Form 6-K filed?
This Form 6-K was filed on January 28, 2025.
Where is Trinity Biotech's principal executive office located?
Trinity Biotech's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Does this filing indicate any new financial results or operational updates?
Based on the provided text, this Form 6-K appears to be a routine report of a foreign private issuer and does not contain specific new financial results or operational updates.
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-01-28 11:33:05
Filing Documents
- zk2532619.htm (6-K) — 16KB
- exhibit_99-1.htm (EX-99.1) — 19KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-25-000249.txt ( ) — 160KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: January 28, 2025